Skip to main content
LIWANLI logo

LIWANLI — Investor Relations & Filings

Ticker · 3054 ISIN · TW0003054003 TW Wholesale and retail trade
Open in API
Filings indexed 1,630 across all filing types
Latest filing 2025-05-09 Regulatory Filings
Country TW Taiwan
Listing TW 3054

About LIWANLI

https://www.liwanli.com.tw

Liwanli Innovation Co., Ltd. is a technology-driven enterprise that transitioned from its origins in mobile multimedia and storage solutions into the biotechnology and healthcare sectors. Originally established in 1991, the company underwent a strategic rebranding in 2015 to focus on the research, development, and distribution of health supplements and nutritional products. Its core operations involve the creation of patented formulas and the application of innovative R&D techniques to meet consumer wellness needs. The company leverages extensive industry-university collaborations and maintains advanced laboratory facilities to ensure the scientific integrity of its product offerings. In addition to its primary focus on biotechnology and health products, the company continues to engage in the sale of electronic components and consumer electronics, emphasizing a philosophy of precision and nutritional excellence.

Recent filings

Filing Released Lang Actions
114年第1季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a brief financial disclosure related to investment in an overseas subsidiary, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (114年1季, which corresponds to Q1 of the 114th year in the Taiwanese calendar). The document length is very short (646 characters), and it contains tabular financial data but no comprehensive financial statements or detailed analysis. It appears to be a regulatory filing or a brief investment disclosure rather than a full financial report like an Annual Report (10-K) or Interim Report (IR). There is no indication of an earnings release, management discussion, or other detailed report. Given the nature and length, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-05-09 Chinese
114年第1季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning investments in mainland China by a Taiwanese listed company. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, recognized investment gains or losses, and regulatory approval limits. The document is relatively short (1295 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an announcement of a report publication, nor a certification or a general regulatory filing. The content aligns with a regulatory disclosure related to investments, which typically falls under Regulatory Filings (RNS) as it does not fit the other more specific categories like Annual Report, Interim Report, or Capital/Financing Update. Therefore, the best classification is Regulatory Filings (RNS).
2025-05-09 Chinese
114年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company providing information about fund loans and endorsement guarantees, all reported as zero. It is a regulatory disclosure of financial status related to guarantees and loans, without detailed financial statements or management commentary. The document is short (602 characters) and contains tabular data on financial guarantees and loans, typical of a regulatory filing or compliance disclosure rather than a full financial report or announcement. There is no indication of an annual or quarterly report, audit report, or other specific filings. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance disclosure.
2025-05-08 Chinese
114年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized revenue report for a company named 立萬利, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting requirements. The document is short (763 characters) and primarily provides financial summary data for a specific month and year (April 114 in the ROC calendar, equivalent to 2025). It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). It is more of a brief financial summary or factsheet. Given the brief nature and summary format, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2025-05-08 Chinese
114年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and stock ownership information of company insiders, including directors, general managers, and other key personnel. It shows changes in shareholdings, types of shares held, and related notes about identities and roles. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider shareholdings and transactions by directors and executives. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is substantive insider shareholding data, not a mere announcement or certification. Therefore, the appropriate classification is DIRS.
2025-05-06 Chinese
114年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings of company insiders, including directors, independent directors, general manager, major shareholders, and financial department heads. It lists the number of shares held, pledged shares, and related percentages. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is a report of personal share transactions or holdings by company directors and executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 2612 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2025-05-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.